2023 Q3 Form 10-Q Financial Statement

#000175015523000054 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q4
Revenue $14.29M $16.01M $18.87M
YoY Change -16.1% -15.21% -24.01%
Cost Of Revenue $6.365M $7.088M $29.44M
YoY Change -21.34% -25.83% 42.74%
Gross Profit $7.929M $8.918M -$10.57M
YoY Change -11.36% -4.32% -351.28%
Gross Profit Margin 55.47% 55.72% -56.02%
Selling, General & Admin $19.89M $19.63M $21.41M
YoY Change 80.28% 13.72% -12.16%
% of Gross Profit 250.84% 220.08%
Research & Development $916.0K
YoY Change
% of Gross Profit 10.27%
Depreciation & Amortization $3.740M $3.977M $3.206M
YoY Change 105.27% 113.59% 14.62%
% of Gross Profit 47.17% 44.6%
Operating Expenses $19.89M $19.63M $21.41M
YoY Change 80.28% 13.72% -12.16%
Operating Profit -$11.96M -$10.71M -$31.98M
YoY Change 205.96% 34.91% 58.55%
Interest Expense -$4.020M $14.93M -$3.580M
YoY Change 0.5% -1131.7%
% of Operating Profit
Other Income/Expense, Net $841.0K -$1.376M $440.0K
YoY Change 161.99% -2123.53% -263.57%
Pretax Income -$15.14M $2.844M -$35.14M
YoY Change 99.57% -136.14% -70.25%
Income Tax $0.00 $0.00 $91.00K
% Of Pretax Income 0.0%
Net Earnings -$15.14M $2.844M -$35.23M
YoY Change 99.57% -136.14% -70.21%
Net Earnings / Revenue -105.94% 17.77% -186.71%
Basic Earnings Per Share -$0.10 $0.02
Diluted Earnings Per Share -$0.10 $0.02 -$0.23
COMMON SHARES
Basic Shares Outstanding 153.0M shares 152.4M shares 151.6M shares
Diluted Shares Outstanding 153.1M shares 152.8M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $51.00M $61.73M $66.96M
YoY Change 208.85% 316.6% 243.51%
Cash & Equivalents $51.02M $61.73M $66.96M
Short-Term Investments
Other Short-Term Assets $7.600M $6.900M $7.998M
YoY Change 67.77% 57.18% -1.2%
Inventory $22.63M $23.76M $26.95M
Prepaid Expenses $2.612M
Receivables $2.492M $2.479M $1.847M
Other Receivables $0.00 $0.00 $573.0K
Total Short-Term Assets $83.74M $94.86M $103.8M
YoY Change 12.89% 15.17% 8.3%
LONG-TERM ASSETS
Property, Plant & Equipment $28.06M $26.61M $29.33M
YoY Change -9.75% -19.17% -18.72%
Goodwill $0.00
YoY Change
Intangibles $1.382M $1.500M $1.771M
YoY Change -31.52% -35.82% -37.71%
Long-Term Investments $11.10M $10.70M $0.00
YoY Change
Other Assets $1.389M $1.515M $5.770M
YoY Change -76.91% -20.18% 179.83%
Total Long-Term Assets $80.12M $81.73M $83.88M
YoY Change 20.78% 15.68% 10.8%
TOTAL ASSETS
Total Short-Term Assets $83.74M $94.86M $103.8M
Total Long-Term Assets $80.12M $81.73M $83.88M
Total Assets $163.9M $176.6M $187.6M
YoY Change 16.62% 15.41% 9.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.577M $3.193M $4.018M
YoY Change 38.43% -37.66% -20.42%
Accrued Expenses $7.221M $8.336M $6.899M
YoY Change -2.88% 14.13% -27.91%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $445.0K
YoY Change -91.98%
Total Short-Term Liabilities $24.78M $22.61M $21.43M
YoY Change 88.49% 27.08% 6.23%
LONG-TERM LIABILITIES
Long-Term Debt $40.40M $40.31M $37.43M
YoY Change 118.3% 108.86% 79.21%
Other Long-Term Liabilities $35.00M $35.31M $51.28M
YoY Change 1749900.0% 294166.67% 427258.33%
Total Long-Term Liabilities $75.40M $75.62M $88.71M
YoY Change 3769900.0% 630058.33% 739150.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $24.78M $22.61M $21.43M
Total Long-Term Liabilities $75.40M $75.62M $88.71M
Total Liabilities $100.1M $98.23M $110.1M
YoY Change 216.3% 164.75% 168.19%
SHAREHOLDERS EQUITY
Retained Earnings -$263.1M -$248.0M -$247.9M
YoY Change 23.71% 20.91% 31.45%
Common Stock $1.000K $1.000K $1.000K
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.74M $78.36M $77.51M
YoY Change
Total Liabilities & Shareholders Equity $163.9M $176.6M $187.6M
YoY Change 16.62% 15.41% 9.4%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q4
OPERATING ACTIVITIES
Net Income -$15.14M $2.844M -$35.23M
YoY Change 99.57% -136.14% -70.21%
Depreciation, Depletion And Amortization $3.740M $3.977M $3.206M
YoY Change 105.27% 113.59% 14.62%
Cash From Operating Activities -$7.840M $1.064M -$2.716M
YoY Change -565.28% 169.37% -56.44%
INVESTING ACTIVITIES
Capital Expenditures $2.830M $187.0K -$146.0K
YoY Change -3728.21% -401.61% -82.41%
Acquisitions
YoY Change
Other Investing Activities $80.00K $76.00K $306.0K
YoY Change -77.4% 133.59%
Cash From Investing Activities -$2.750M -$111.0K $452.0K
YoY Change -1096.38% 79.03% -164.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -120.0K -6.000K 52.71M
YoY Change -54.72% -53.85% 883.65%
NET CHANGE
Cash From Operating Activities -7.840M 1.064M -2.716M
Cash From Investing Activities -2.750M -111.0K 452.0K
Cash From Financing Activities -120.0K -6.000K 52.71M
Net Change In Cash -10.71M 947.0K 50.45M
YoY Change -731.49% 195.94% -3303.17%
FREE CASH FLOW
Cash From Operating Activities -$7.840M $1.064M -$2.716M
Capital Expenditures $2.830M $187.0K -$146.0K
Free Cash Flow -$10.67M $877.0K -$2.570M
YoY Change -705.22% 91.9% -52.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
45000 usd
CY2022Q1 cweb Stock Issued During Period Value Asset Acquisition
StockIssuedDuringPeriodValueAssetAcquisition
165000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-2000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1214000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-8626000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
123152000 usd
CY2022Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
13000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
643000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
115912000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16496000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7769000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3940000 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
9612000 usd
cweb Change In Fair Value Of Financial Instruments Gain Loss
ChangeInFairValueOfFinancialInstrumentsGainLoss
100000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
10700000 usd
us-gaap Gain Loss On Investments
GainLossOnInvestments
0 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1954000 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
999000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2022000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-979000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
976000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1236000 usd
us-gaap Inventory Write Down
InventoryWriteDown
320000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1857000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
957000 usd
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-434000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1104000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2430000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2878000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2411000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-764000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3706000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
183000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2194000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
1436000 usd
cweb Increase Decrease In Operating Lease Right Of Use Assets And Operating Lease Liability
IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndOperatingLeaseLiability
896000 usd
cweb Increase Decrease In License Payable
IncreaseDecreaseInLicensePayable
4000000 usd
cweb Increase Decrease In License Payable
IncreaseDecreaseInLicensePayable
0 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4261000 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3185000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
130000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
129000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5009000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4284000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
187000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
333000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
36000 usd
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-333000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-75000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-60000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-75000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-60000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5235000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4677000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
66963000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19494000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61728000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14817000 usd
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
163000 usd
us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0 usd
us-gaap Notes Issued1
NotesIssued1
156000 usd
us-gaap Notes Issued1
NotesIssued1
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
33016000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
38234000 usd
CY2023Q2 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2057000 usd
CY2023Q2 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2057000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
836000 usd
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
2893000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
10700000 usd
CY2023Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2815000 usd
CY2022Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2300000 usd
CY2022Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2300000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
1320000 usd
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
3620000 usd
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
12995000 usd
CY2021Q1 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd
CY2021Q1 cweb Business Combination Purchase Option Term
BusinessCombinationPurchaseOptionTerm
P5Y
CY2021Q1 cweb Business Combination Purchase Option Extension Term
BusinessCombinationPurchaseOptionExtensionTerm
P2Y
CY2021Q1 cweb C Class Of Warrant Or Right Percentage Of Outstanding Shares
CClassOfWarrantOrRightPercentageOfOutstandingShares
0.10
CY2021Q4 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P60D
CY2023Q2 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
57000 usd
CY2022Q2 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
0 usd
CY2023Q1 cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
-243000 usd
cweb Gain Loss On Fair Value Adjustment Business Combination Purchase Option
GainLossOnFairValueAdjustmentBusinessCombinationPurchaseOption
100000 usd
CY2023Q2 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2057000 usd
CY2022Q4 cweb Business Combination Purchase Option
BusinessCombinationPurchaseOption
2300000 usd
CY2023Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
20991000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
34763000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
10440000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
10960000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
10071000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
13237000 usd
CY2023Q2 us-gaap Inventory Gross
InventoryGross
41502000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
58960000 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
17747000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
32007000 usd
CY2023Q2 cweb Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
23755000 usd
CY2022Q4 cweb Inventory Current And Noncurrent
InventoryCurrentAndNoncurrent
26953000 usd
cweb Inventory Provision Period Increase Decrease
InventoryProvisionPeriodIncreaseDecrease
-12899000 usd
CY2023Q2 cweb Licensed Properties
LicensedProperties
18235000 usd
CY2022Q4 cweb Licensed Properties
LicensedProperties
23399000 usd
CY2023Q2 cweb Media Rights
MediaRights
7232000 usd
CY2022Q4 cweb Media Rights
MediaRights
7482000 usd
CY2023Q2 cweb License Payable Current
LicensePayableCurrent
8833000 usd
CY2023Q2 cweb License Payable Noncurrent
LicensePayableNoncurrent
15869000 usd
CY2023Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1710000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3201000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2892000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2169000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1844000 usd
CY2023Q2 cweb Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
13647000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25463000 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6687000 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
18776000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2247000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16529000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
2844000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-7870000 usd
us-gaap Net Income Loss
NetIncomeLoss
-67000 usd
us-gaap Net Income Loss
NetIncomeLoss
-16496000 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152481470 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145168510 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
152398273 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145079859 shares
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
278618 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152760088 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145168510 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
152398273 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145079859 shares
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9411551 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.888
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.834
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.034
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.033
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Share Price
SharePrice
0.36
CY2022Q2 us-gaap Share Price
SharePrice
0.31
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3957027 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.52
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y4M13D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
46800 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3748671 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.38
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
692991 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.28
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7012707 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.83
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y11M26D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2554000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.21
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y6M10D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.38
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.14
cweb Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice
0
cweb Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Share Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageSharePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
872000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
625000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2569574 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
1249548 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.38
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
299370 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
1.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
690092 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
1.26
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriod
152198 shares
cweb Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Withheld In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsWithheldInPeriodWeightedAverageGrantDateFairValue
0.85
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
2677462 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0.67
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
624000 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
643000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
999000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2022000 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
4074000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y5M26D
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4106000 usd
CY2023Q2 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
4261000 usd
CY2023Q2 cweb Interest Income On Income Tax Refund Amount
InterestIncomeOnIncomeTaxRefundAmount
155000 usd
CY2020Q4 us-gaap Related Party Transaction Rate
RelatedPartyTransactionRate
0.0325
CY2021Q1 cweb Payment For Business Combination Purchase Option
PaymentForBusinessCombinationPurchaseOption
8000000 usd

Files In Submission

Name View Source Status
0001750155-23-000054-index-headers.html Edgar Link pending
0001750155-23-000054-index.html Edgar Link pending
0001750155-23-000054.txt Edgar Link pending
0001750155-23-000054-xbrl.zip Edgar Link pending
cweb-20230630.htm Edgar Link pending
cweb-20230630.xsd Edgar Link pending
ex311.htm Edgar Link pending
ex312.htm Edgar Link pending
ex321.htm Edgar Link pending
ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
cweb-20230630_cal.xml Edgar Link unprocessable
cweb-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cweb-20230630_lab.xml Edgar Link unprocessable
cweb-20230630_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
cweb-20230630_def.xml Edgar Link unprocessable